Impact of a Meds-to-Beds PCSK9i Initiation Program on LDL-C in Patients Undergoing ASCVD Revascularization
Early initiation of guideline-recommended PCSK9i mAbs through a dedicated M2B program was associated with enhanced attainment of LDL-C goals in patients with established atherosclerotic cardiovascular disease undergoing revascularization.
Authors
- Bethany Kalich (ORCID: https://orcid.org/0000-0002-1220-3484)
- Vita Jaspan
- Colette V. Browne (ORCID: https://orcid.org/0000-0003-0457-7379)
- Evan C. Lipsitz
- Annalisa Filtz
- Leandro N. Slipczuk (ORCID: https://orcid.org/0000-0003-3091-3735)
- Laney K. Jones (ORCID: https://orcid.org/0000-0002-6182-5634)
- Michael D. Shapiro (ORCID: https://orcid.org/0000-0002-9071-3287)
- Katherine E. Di Palo (ORCID: https://orcid.org/0000-0003-1558-4718)
- Andrea Scotti (ORCID: https://orcid.org/0000-0003-4731-4384)
- Carlos J. Rodríguez (ORCID: https://orcid.org/0000-0003-3618-9514)
- S. Forest (ORCID: https://orcid.org/0000-0002-8402-8267)
- Martha Gulati (ORCID: https://orcid.org/0000-0003-0735-9756)
- Daniel Lorenzatti (ORCID: https://orcid.org/0000-0002-4467-167X)
- Azeem Latib (ORCID: https://orcid.org/0000-0001-9035-343X)
- G Greenberg (ORCID: https://orcid.org/0000-0002-7426-1815)
- Christine M. Park (ORCID: https://orcid.org/0000-0001-8732-5307)
- Niranjan Kathe (ORCID: https://orcid.org/0000-0003-4932-6426)
- Mario J. García (ORCID: https://orcid.org/0000-0002-7503-0285)
Institutions
- Albert Einstein College of Medicine (US)
- Amgen (United States) (US)
- Montefiore Medical Center (US)
- Montefiore Health System (US)
- Cedars-Sinai Smidt Heart Institute (US)
- Wake Forest University (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1016/j.jacadv.2025.102075
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen